Literature DB >> 16998758

Intravenous immunoglobulin therapy in neurological diseases during pregnancy.

Isabel Ringel1, Uwe K Zettl.   

Abstract

Immunological changes during pregnancy influence the course of neurological autoimmune diseases in different ways. In case of pregnancy immunomodulatory standard therapies such as interferon-beta, glatiramer acetate,monoclonal antibodies and cytostatics mostly should be discontinued. In those cases intravenous immunoglobulin (IVIg) therapy might be an alternative. In some diseases, contemporary publications describe positive therapeutic effects on the course of disease during or after pregnancy.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16998758     DOI： 10.1007/s00415-006-5012-0

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  67 in total

1.  Clinical and electrophysiologic improvement in Lambert-Eaton syndrome with intravenous immunoglobulin therapy.

Authors:  S J Bird
Journal:  Neurology       Date:  1992-07       Impact factor: 9.910

2.  Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy.

Authors:  M Marzi; A Vigano; D Trabattoni; M L Villa; A Salvaggio; E Clerici; M Clerici
Journal:  Clin Exp Immunol       Date:  1996-10       Impact factor: 4.330

3.  Guillain-Barré syndrome in pregnancy. Respiratory paralysis complicated by a fatal tracheo-innominate artery fistula.

Authors:  M Elstein; N J Legg; M Murphy; D M Park; M M Sutcliffe
Journal:  Anaesthesia       Date:  1971-04       Impact factor: 6.955

Review 4.  IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.

Authors:  Isabel Illa
Journal:  J Neurol       Date:  2005-05       Impact factor: 4.849

5.  Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  J R Mendell; R J Barohn; M L Freimer; J T Kissel; W King; H N Nagaraja; R Rice; W W Campbell; P D Donofrio; C E Jackson; R A Lewis; M Shy; D M Simpson; G J Parry; M H Rivner; C A Thornton; M B Bromberg; R Tandan; Y Harati; M J Giuliani
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

Review 6.  Guillain-Barré syndrome in pregnancy.

Authors:  Louis Yik-Si Chan; Michelle Hang-Yuet Tsui; Tse Ngong Leung
Journal:  Acta Obstet Gynecol Scand       Date:  2004-04       Impact factor: 3.636

7.  Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment.

Authors:  R M Van den Berg-Vos; H Franssen; J H J Wokke; L H Van den Berg
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

Review 8.  Rheumatoid arthritis and pregnancy.

Authors:  G L Klipple; F A Cecere
Journal:  Rheum Dis Clin North Am       Date:  1989-05       Impact factor: 2.670

9.  Deterioration of multifocal motor neuropathy after plasma exchange.

Authors:  M Carpo; A Cappellari; G Mora; R Pedotti; S Barbieri; G Scarlato; E Nobile-Orazio
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

10.  Dermatomyositis developing in the first trimester of pregnancy.

Authors:  In Whee Park; Yu Jin Suh; Jae Ho Han; Yoo Seob Shin; Jeong Hee Choi; Hae Sim Park; Chang Hee Suh
Journal:  Korean J Intern Med       Date:  2003-09       Impact factor: 2.884
View more
  3 in total

Review 1.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

2.  Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series.

Authors:  Yára D Fragoso; Alessandro Finkelsztejn; Damacio R Kaimen-Maciel; Anderson K Grzesiuk; Andre S Gallina; Josiane Lopes; Nivea M O Morales; Soniza V Alves-Leon; Sandra M G de Almeida
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

3.  Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE).

Authors:  Diana Straubel; Anja Thielitz; Annegret Reinhold; Kurt Grüngreiff; Dirk Reinhold
Journal:  J Immunol Res       Date:  2018-09-26       Impact factor: 4.818
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.